<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 26 Feb 2021 23:47:34 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>降糖药市场风起云涌，行业内大咖都有哪些？！</title><link>https://mp.weixin.qq.com/s/IyOEWLSqxYJ_VxZaFX4jlg</link><description></description><content:encoded><![CDATA[降糖药市场风起云涌，行业内大咖都有哪些？！]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:39:18 +0800</pubDate></item><item><title>主力孕吐止呕药，携优异安全性、无专利优势往前冲吧！</title><link>https://mp.weixin.qq.com/s/AhUDxPIiCp-nl3UX_6TL0Q</link><description></description><content:encoded><![CDATA[主力孕吐止呕药，携优异安全性、无专利优势往前冲吧！]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:39:18 +0800</pubDate></item><item><title>国采最新进度：阿比特龙完成度超4792%！</title><link>https://mp.weixin.qq.com/s/pYsURfpty3NTOgpjby_udA</link><description></description><content:encoded><![CDATA[国采最新进度：阿比特龙完成度超4792%！]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:39:18 +0800</pubDate></item><item><title>一药企撤网品种高达6个</title><link>https://mp.weixin.qq.com/s/IJTasgJW8Z-JiuVu9FmWmA</link><description></description><content:encoded><![CDATA[一药企撤网品种高达6个]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:39:18 +0800</pubDate></item><item><title>2021年，最有望获批的十个重磅首仿药</title><link>https://mp.weixin.qq.com/s/v8RbBltoYagYHjGE6Csn6w</link><description></description><content:encoded><![CDATA[2021年，最有望获批的十个重磅首仿药]]></content:encoded><pubDate>Thu, 25 Feb 2021 21:40:53 +0800</pubDate></item><item><title>大批药品降价了，最高降幅79.7%！</title><link>https://mp.weixin.qq.com/s/qwB9lL6dzUZHXdRRuHXpdQ</link><description></description><content:encoded><![CDATA[大批药品降价了，最高降幅79.7%！]]></content:encoded><pubDate>Thu, 25 Feb 2021 21:40:53 +0800</pubDate></item><item><title>医保目录将迎来大变动</title><link>https://mp.weixin.qq.com/s/wOjWcWIHuPSiktnPcoLJKQ</link><description></description><content:encoded><![CDATA[医保目录将迎来大变动]]></content:encoded><pubDate>Thu, 25 Feb 2021 21:40:53 +0800</pubDate></item><item><title>第五批国采，这些品种大概率纳入？</title><link>https://mp.weixin.qq.com/s/waOGS2xZAH0AAt9Fq6mzYg</link><description></description><content:encoded><![CDATA[第五批国采，这些品种大概率纳入？]]></content:encoded><pubDate>Thu, 25 Feb 2021 21:40:53 +0800</pubDate></item><item><title>（2021.2.24）最新一致性评价名单，6品种前三家过评！</title><link>https://mp.weixin.qq.com/s/mRSgx3vE5DoZBUiPkhpKdA</link><description></description><content:encoded><![CDATA[（2021.2.24）最新一致性评价名单，6品种前三家过评！]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:35:31 +0800</pubDate></item><item><title>40亿抗心衰大品种，人福获FDA批准上市</title><link>https://mp.weixin.qq.com/s/ceO2pDcnVJGSoP-g0BY_jg</link><description></description><content:encoded><![CDATA[40亿抗心衰大品种，人福获FDA批准上市]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:35:31 +0800</pubDate></item><item><title>第三十八批参比目录发布，51个新增，18个变更...</title><link>https://mp.weixin.qq.com/s/2K_1PPm1TLr2JNL_EiMYlw</link><description></description><content:encoded><![CDATA[第三十八批参比目录发布，51个新增，18个变更...]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:35:31 +0800</pubDate></item><item><title>药价差超2倍，须下调30%或至最低价2倍</title><link>https://mp.weixin.qq.com/s/cAsr-Qf2bS6ODNZCVjyTwQ</link><description></description><content:encoded><![CDATA[药价差超2倍，须下调30%或至最低价2倍]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:35:31 +0800</pubDate></item><item><title>年销超35亿的重磅注射剂，离集采之路还有多远？</title><link>https://mp.weixin.qq.com/s/A-dzlgINRc2elwnI4aoh9A</link><description></description><content:encoded><![CDATA[年销超35亿的重磅注射剂，离集采之路还有多远？]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:38:27 +0800</pubDate></item><item><title>单品种上亿的市场，这款哮喘病-手性药物有望接力！</title><link>https://mp.weixin.qq.com/s/MCrWf5MTEOxWwYWHV7iPZQ</link><description></description><content:encoded><![CDATA[单品种上亿的市场，这款哮喘病-手性药物有望接力！]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:38:27 +0800</pubDate></item><item><title>CDE：技术审评报告工作规范（试行），提及“商业秘密”部分</title><link>https://mp.weixin.qq.com/s/yBVljHiKQAC6g4yR5AXnvQ</link><description></description><content:encoded><![CDATA[CDE：技术审评报告工作规范（试行），提及“商业秘密”部分]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:38:27 +0800</pubDate></item><item><title>第四批国采，最新执行通知发布！</title><link>https://mp.weixin.qq.com/s/PnfhVnsgL_gdRjvuBtpogw</link><description></description><content:encoded><![CDATA[第四批国采，最新执行通知发布！]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:38:27 +0800</pubDate></item><item><title>这批药品降价了</title><link>https://mp.weixin.qq.com/s/OyuKXU1KcHq3ikpHDgpGEQ</link><description></description><content:encoded><![CDATA[这批药品降价了]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:38:27 +0800</pubDate></item><item><title>无专利限制，高技术壁垒...曲普瑞林-机遇与挑战并存</title><link>https://mp.weixin.qq.com/s/W_IuWZtdf1w4gTrIGVmFzQ</link><description></description><content:encoded><![CDATA[无专利限制，高技术壁垒...曲普瑞林-机遇与挑战并存]]></content:encoded><pubDate>Mon, 22 Feb 2021 21:36:58 +0800</pubDate></item><item><title>知名大三甲：这些药品短缺，直接挂网（附最新中标价）</title><link>https://mp.weixin.qq.com/s/3imDPF6SChL7JlAPR4dp0A</link><description></description><content:encoded><![CDATA[知名大三甲：这些药品短缺，直接挂网（附最新中标价）]]></content:encoded><pubDate>Mon, 22 Feb 2021 21:36:58 +0800</pubDate></item><item><title>「4+7」第二年续约期到来...</title><link>https://mp.weixin.qq.com/s/9isGKrYPfmDdqCc0sbRuyw</link><description></description><content:encoded><![CDATA[「4+7」第二年续约期到来...]]></content:encoded><pubDate>Mon, 22 Feb 2021 21:36:58 +0800</pubDate></item></channel></rss>